Determinants of long-term fatigue in breast cancer survivors: results of a prospective patient cohort study

Objective Fatigue is among the most distressing symptoms across the breast cancer continuum. However, little is known about the factors contributing to long‐term persisting fatigue. Therefore, we explored determinants of long‐term physical, affective, and cognitive fatigue in a prospective cohort of...

Full description

Saved in:
Bibliographic Details
Published inPsycho-oncology (Chichester, England) Vol. 24; no. 1; pp. 40 - 46
Main Authors Schmidt, Martina E., Chang-Claude, Jenny, Seibold, Petra, Vrieling, Alina, Heinz, Judith, Flesch-Janys, Dieter, Steindorf, Karen
Format Journal Article
LanguageEnglish
Published England Blackwell Publishing Ltd 01.01.2015
Wiley Subscription Services, Inc
Subjects
Online AccessGet full text
ISSN1057-9249
1099-1611
1099-1611
DOI10.1002/pon.3581

Cover

More Information
Summary:Objective Fatigue is among the most distressing symptoms across the breast cancer continuum. However, little is known about the factors contributing to long‐term persisting fatigue. Therefore, we explored determinants of long‐term physical, affective, and cognitive fatigue in a prospective cohort of breast cancer patients. Methods Breast cancer patients recruited in a population‐based case–control study (MARIE study) provided comprehensive data on sociodemographics, lifestyle, and preexisting medical conditions. At follow‐up (median 6.3 years post‐diagnosis, MARIEplus), disease‐free cancer survivors (N = 1928) reported current fatigue using a validated multidimensional questionnaire. Additionally, survivors retrospectively rated their fatigue levels before diagnosis, during the treatment phase, and 1 year post‐surgery. Linear regression analyses were performed. Results As major determinants of long‐term physical, affective, and cognitive fatigue, multiple regression analyses revealed preexisting psychological or depressive disorders, migraine, analgesic use, peripheral arterial obstructive disease (PAOD), and arthritis. A physically inactive lifestyle and obesity were associated with persisting physical fatigue. Aromatase inhibitors were also associated with long‐term fatigue, especially cognitive fatigue. Chemotherapy and, to a lower extent, radiotherapy were major contributors to the development of fatigue during the treatment phase, yet were not associated with long‐term fatigue. Conclusions Although the development of fatigue in breast cancer patients seems largely impacted by cancer therapy, for the long‐term persistence of fatigue, preexisting medical or psychological conditions related to depression or pain and lifestyle factors appear to be more relevant. Physicians, psycho‐oncologists, and researchers may need to distinguish between acute fatigue during therapy and long‐term persisting fatigue with regard to its pathophysiology and treatment. Copyright © 2014 John Wiley & Sons, Ltd.
Bibliography:istex:4C8AE69EFCFC843F00ED076A0A18B830DC883B5E
ArticleID:PON3581
Deutsche Krebshilfe e. V. - No. 70-2892-BR I; No. 108253/108419
Hamburg Cancer Society, the German Cancer Research Centre, and the German Federal Ministry for Education and Research - No. 01KH0402
ark:/67375/WNG-RKXQ597M-5
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 14
ObjectType-Article-1
ObjectType-Feature-2
content type line 23
ObjectType-Article-2
ISSN:1057-9249
1099-1611
1099-1611
DOI:10.1002/pon.3581